Vistagen Therapeutics, Inc. (VTGN): Revenue
$1.27M
Year ended 2026-03-31
$2.50M
Trailing 12 months to 2026-06-30
+3.1%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $1.27M | +161.1% | 2026-06-15, From 2025-04-01 |
| 2025-03-31 | $486.0K | -54.3% | 2026-06-15, From 2024-04-01 |
| 2024-03-31 | $1.06M | n/a | 2025-06-17, From 2023-04-01 |
| No annual figure between 2022-03-31 and 2024-03-31. | |||
| 2022-03-31 | $1.11M | +1.8% | 2023-06-28, From 2021-04-01 |
| 2021-03-31 | $1.09M | n/a | 2022-06-23, From 2020-04-01 |
| 2020-03-31 | $0 | n/a | 2021-06-29, From 2019-04-01 |
| No annual figure between 2018-03-31 and 2020-03-31. | |||
| 2018-03-31 | $0 | -100.0% | 2018-06-26, From 2017-04-01 |
| 2017-03-31 | $1.25M | n/a | 2018-06-26, From 2016-04-01 |
| 2016-03-31 | $0 | n/a | 2017-06-29, From 2015-04-01 |
| No annual figure between 2013-03-31 and 2016-03-31. | |||
| 2013-03-31 | $200.4K | -85.1% | 2014-06-25, From 2012-04-01 |
| 2012-03-31 | $1.34M | -35.2% | 2013-07-18, From 2011-04-01 |
| 2011-03-31 | $2.07M | n/a | 2012-07-02, From 2010-04-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $1.27M | +161.1% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $1.27M | -5.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $1.20M | -49.9% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $1.36M | +66.1% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $1.17M | -92.5% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $1.38M | -0.3% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.40M | n/a |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $1.14M | -34.6% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $1.12M | +42.3% |
Compare VTGN, IGC, LGVN, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗